These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14517185)

  • 1. Antiangiogenic therapy: more promise and, yet again, more questions.
    Ellis LM
    J Clin Oncol; 2003 Nov; 21(21):3897-9. PubMed ID: 14517185
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies.
    Morgan B; Thomas AL; Drevs J; Hennig J; Buchert M; Jivan A; Horsfield MA; Mross K; Ball HA; Lee L; Mietlowski W; Fuxuis S; Unger C; O'Byrne K; Henry A; Cherryman GR; Laurent D; Dugan M; Marmé D; Steward WP
    J Clin Oncol; 2003 Nov; 21(21):3955-64. PubMed ID: 14517187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: implication for antiangiogenic approach to hepatocellular carcinoma.
    Yau T; Chan P; Pang R; Ng K; Fan ST; Poon RT
    Cancer; 2010 Nov; 116(21):5022-9. PubMed ID: 20629034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases.
    Lee L; Sharma S; Morgan B; Allegrini P; Schnell C; Brueggen J; Cozens R; Horsfield M; Guenther C; Steward WP; Drevs J; Lebwohl D; Wood J; McSheehy PM
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):761-71. PubMed ID: 16172907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current studies with PTK787, an oral inhibitor of vascular endothelial growth factor in colorectal cancer.
    Klem J
    Clin Colorectal Cancer; 2003 Nov; 3(3):147-9. PubMed ID: 14706172
    [No Abstract]   [Full Text] [Related]  

  • 6. Perfusion chemotherapy for colorectal liver metastases: a randomized study comparing FUDR against 5-FU/BCNU.
    Schmitz R; Krakamp B; Troidl H
    J Chemother; 1989 Jul; 1(4 Suppl):1216-7. PubMed ID: 16312840
    [No Abstract]   [Full Text] [Related]  

  • 7. Metastatic colorectal cancer.
    Bouche O; Conroy T; Michel P; Penna C; Tournigand C
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S30-2S42. PubMed ID: 17151561
    [No Abstract]   [Full Text] [Related]  

  • 8. Future directions with angiogenesis inhibitors in colorectal cancer.
    Bilenker JH; Haller DG
    Clin Colorectal Cancer; 2004 Oct; 4 Suppl 2():S86-93. PubMed ID: 15479485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trials on preoperative chemotherapy in resectable colorectal liver metastases need prospective evaluation of predictive factors of response.
    Nasti G; Ottaiano A; Rosario Iaffaioli V; Berretta M; Delrio P
    J Clin Oncol; 2008 Aug; 26(22):3812-3; author reply 3813. PubMed ID: 18669474
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic chemotherapy and its implications for resection of colorectal liver metastasis.
    Robinson S; Manas DM; Pedley I; Mann D; White SA
    Surg Oncol; 2011 Jun; 20(2):57-72. PubMed ID: 19962301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal liver metastasis--past, present, and the future.
    Jabbour N; Singhal A; Sharma S
    J Okla State Med Assoc; 2009 Nov; 102(11):351-3. PubMed ID: 20034247
    [No Abstract]   [Full Text] [Related]  

  • 12. [An new generation of antineoplastic agents--targeted therapy in gastrointestinal tumors].
    Lang A; Graeven U
    Zentralbl Chir; 2009 Jun; 134(3):189-92. PubMed ID: 19544236
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving long-term outcomes for patients with liver metastases from colorectal cancer.
    Chong G; Cunningham D
    J Clin Oncol; 2005 Dec; 23(36):9063-6. PubMed ID: 16301589
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency.
    Sugimoto M; Yasuda H; Koda K; Yamazaki M; Tezuka T; Takenoue T; Kosugi C; Higuchi R; Yamamoto S; Watayo Y; Yagawa Y; Suzuki M
    Hepatogastroenterology; 2007 Sep; 54(78):1684-8. PubMed ID: 18019695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver metastases of colorectal cancer: medical treatments.
    Pasetto LM; Rossi E; Monfardini S
    Anticancer Res; 2003; 23(5b):4245-56. PubMed ID: 14666634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy in metastatic colorectal cancer.
    Kelly C; Cassidy J
    Surg Oncol; 2007 Jul; 16(1):65-70. PubMed ID: 17521906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does chemotherapy given directly to the liver improve survival in patients with hepatic metastasis?
    Kerr DJ
    Nat Clin Pract Oncol; 2006 Sep; 3(9):480-1. PubMed ID: 16955085
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolving role of chemotherapy in resected liver metastases.
    Alberts SR
    J Clin Oncol; 2006 Nov; 24(31):4952-3. PubMed ID: 17075111
    [No Abstract]   [Full Text] [Related]  

  • 19. A role for hepatic-directed chemotherapy in colorectal liver metastases.
    Ensminger WD
    J Clin Oncol; 2005 Aug; 23(22):4815-7. PubMed ID: 16009957
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined chemotherapy with oral leucovorin (LV) + tegafur/uracil (UFT) and hepatic arterial infusion (HAI) therapy for liver metastasis of colorectal cancer].
    Hasegawa S; Matsumoto S; Kawashima K; Fujii H; Hatano E; Satoh S; Ikai I; Shimahara Y
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):1045-9. PubMed ID: 16044971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.